Mot de passe
Afficher le mot de passe
Mot de passe oublié ?
Devenir membre gratuitement
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Cotations dynamiques 


SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur GILEAD SCIENCES, INC.
15/10GILEAD SCIENCES : Says Breast Cancer Therapy Receives Positive Opinion by European Medicin..
15/10GILEAD SCIENCES : Sacituzumab Govitecan Receives Positive CHMP Opinion as 2L Treatment for..
15/10Gilead's Sacituzumab Govitecan Gets Positive CHMP Opinion in Breast Cancer
14/10GILEAD SCIENCES : to Release Third Quarter 2021 Financial Results on Thursday, October 28,..
14/10EFFECTEN-SPIEGEL AG : Net Asset Value zum 30.09.2021
14/10VC DAILY : Sprinter Health Collects $33 Million to Join Home-Healthcare Race
13/10PRESS RELEASE : NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug Program ..
13/10PRESS RELEASE : NanoViricides, Inc. Has Filed its -2-
11/10EU assesses Regeneron/Roche COVID-19 antibody cocktail for authorisation
11/10REGENERON PHARMACEUTICALS : Merck seeks first U.S. authorization for COVID-19 pill
11/10GILEAD SCIENCES : Merck solicita la autorización de emergencia para su píldora contra el C..
11/10GILEAD SCIENCES : Merck applies for U.S. emergency authorization of COVID-19 pill
04/10BOURSE D'AMSTERDAM : Tech en ING zetten AEX lager
04/10Brussel blijft in het rood
04/10GILEAD SCIENCES : Company Unit's Leukemia Drug Gets FDA Approval
04/10KBC Securities verlaagt koersdoel Galapagos
04/10Voldoende patiënten Galapagos voor DIVERSITY fase 3-studie
02/10ROCHE : Malaysia in talks to procure Merck's COVID-19 pills
01/10GILEAD SCIENCES : U.S. FDA Approves Kite's Tecartus® as the First and Only Car T for Adult..
01/10Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sector
30/09GILEAD SCIENCES : Files Supplemental Biologics License Application for Yescarta in Large B..
30/09KITE : Submits Supplemental Biologics License Application to U.S. Food and Drug Administra..
30/09PRESS RELEASE : Phase II/III trial shows Ronapreve(TM) (casirivimab and imdevimab) signifi..
28/09ANALYSE/Exxon und Chevron hinken bei grüner Energie hinter Europäern her
28/09GILEAD SCIENCES : Marks Fifth Approval for Trodelvy in Metastatic Triple-Negative Breast C..
27/09GILEAD SCIENCES : Wins Canada OK on Trodelvy for Triple-Negative Breast Cancer
27/09GILEAD SCIENCES : Marks Fifth Approval for Trodelvy® in Metastatic Triple-Negative Breast ..
27/09Gilead Announces Fifth Approval for Trodelvy in Metastatic Triple-Negative Breast Cance..
27/09GILEAD SCIENCES : COVID SCIENCE-Protein found on infected cells protects virus from immune..
27/09GILEAD SCIENCES : Trodelvy Product Now Recommended As Triple-Negative Breast Cancer Treatm..
27/09GILEAD SCIENCES : Statement on New NCCN Clinical Practice Guidelines in Oncology (NCCN Gui..
27/09GILEAD SCIENCES : Pfizer begins study of oral drug for prevention of COVID-19
23/09++ Analysen des Tages von Dow Jones Newswires (23.09.2021) +++
23/09ANALYSE/Markt für Corona-Behandlungen noch lange nicht abgegrast
23/09GILEAD SCIENCES : Veklury (Remdesivir) Significantly Reduced Risk of Hospitalization in Hi..
22/09GILEAD SCIENCES : Veklury Lowers Hospitalization Risk in COVID-19 Patients in Phase 3 Stud..
22/09BROOKLYN IMMUNOTHERAPEUTICS : Names Roger Sidhu Chief Medical Officer
22/09GILEAD SCIENCES : Veklury® (Remdesivir) Significantly Reduced Risk of Hospitalization in H..
22/09Gilead Sciences, Inc. Announces Positive Results from A Phase 3 Randomized, Double-Blin..
20/09GILEAD SCIENCES : to Present Latest Antiviral Research Data Addressing Urgent Global Needs..
20/09Gilead to Present Latest Antiviral Research Data Addressing Urgent Global Needs in Infe..
17/09GILEAD SCIENCES : Trodelvy Significantly Improved Quality of Life Over Standard of Care in..
17/09GILEAD SCIENCES : New Data Demonstrate Trodelvy Survival Benefit in Metastatic Triple-Nega..
17/09Gritstone bio, Inc. announced that it has received $55 million in funding from Frazier ..
16/09GRITSTONE BIO : Oncology Places 5 Million Shares for $55 Million -- Stock Down 5% After-Ho..
16/09VC DAILY : Venture Capitalists Push Back Against Drug-Pricing Bill
16/09GILEAD SCIENCES' : Late-Stage Study Shows Breast Cancer Drug May Improve Overall Survival
16/09GILEAD SCIENCES : Trodelvy® Significantly Improved Quality of Life Over Standard of Care i..
16/09GILEAD SCIENCES : New Data Demonstrate Trodelvy® Survival Benefit in Metastatic Triple-Neg..
16/09Gilead Sciences, Inc Announces New Data Demonstrate Trodelvy Survival Benefit in Metast..
16/09Gesundheitsgremium zurückhaltend bei Nutzen von Corona-Medikament
16/09Gilead Says Trodelvy Improved Quality of Life in Breast Cancer in Study
16/09Gritstone bio, Inc. announced that it expects to receive $55 million in funding from Fr..
13/09GILEAD SCIENCES : to Present New Data at ESMO Congress 2021 Reinforcing the Practice-chang..
01/09GILEAD SCIENCES : to Present at Upcoming Investor Conference
01/09Pfizer, Merck launch new trials of oral COVID-19 drugs
01/09Pfizer starts dosing patients in oral COVID-19 drug trial
30/08Galapagos CEO met pensioen
27/08EVEREST MEDICINES : Doses First Patient in China Clinical Trial of Cancer Therapy
26/08MARKET CHATTER : US Appeals Court Overturns $1.2 Billion Verdict Against Gilead Sciences, ..
26/08Gilead Sciences wins reversal of $1.2 billion award in patent case with Bristol Myers
25/08Factbox-Major U.S. companies making masks, vaccines mandatory
23/08Pfizer to buy cancer drug developer Trillium in $2.3 billion deal
20/08GILEAD SCIENCES : Says EMA Validates Marketing Authorization Application for HIV-1 Treatme..
19/08GILEAD SCIENCES : European Medicines Agency Validates Gilead's Marketing Authorization App..
19/08Gilead Sciences, Inc. Announces That the Company’s Marketing Authorization Application ..
19/08PTA-NEWS : MetrioPharm AG: Thomas Christély verstärkt Management derMetrioPharm AG als CEO
19/08GlobeNewswire/Thomas Christély verstärkt Management der MetrioPharm AG als CEO
19/08PRESS RELEASE : Thomas Christély Joins Management of MetrioPharm AG as CEO
18/08INSIDER TRENDS : Insider at First Merchants Sells Stock for Taxes Interrupting 90-Day Buy ..
13/08IRW-PRESS : TAAT Global Alternatives Inc. : Jahresrückblick: TAATT fasst sein erstes Betri..
13/08US SOLAR FUND : Investment Manager Unit Appoints New CEO
13/08NEW ENERGY SOLAR : Names CEO; Shares Fall 3%
12/08INSIDER TRENDS : First Merchants Insider Gets Stock Award, Prolongs Buy Trend
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur GILEAD SCIENCES, INC.